Priority Date: 13.05.11 (EP 20110166117)

PHARMACEUTICAL COMPOSITIONS COMPRISING NEUROPILIN INHIBITORS, AND THEIR USE FOR THE PREVENTION AND/OR TREATMENT OF ANGIOGENIC DISORDERS AND CANCERS

  • Application ID: EP12719760
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

Company dna icosa
no operation time available
619.54
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Icosa is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 185 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 13.05.2011 - Priority Date (EP 20110166117)
  • 22.11.2012 - Publication A1 (WO2012156289)
  • 19.03.2014 - Publication A1 (EP2706993)

IPC Classification